- Home
- Publications
- Publication Search
- Publication Details
Title
Galectins in hematological malignancies
Authors
Keywords
-
Journal
CURRENT OPINION IN HEMATOLOGY
Volume 20, Issue 4, Pages 327-335
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2013-05-22
DOI
10.1097/moh.0b013e328362370f
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Acute Myeloid Leukemia
- (2017) Journal of the National Comprehensive Cancer Network
- Higher bone marrow LGALS3 expression is an independent unfavorable prognostic factor for overall survival in patients with acute myeloid leukemia
- (2013) C.-L. Cheng et al. BLOOD
- Galectin-1 serum levels reflect tumor burden and adverse clinical features in classical Hodgkin lymphoma
- (2013) J. Ouyang et al. BLOOD
- Chronic myeloid leukemia: 2012 update on diagnosis, monitoring, and management
- (2012) Elias Jabbour et al. AMERICAN JOURNAL OF HEMATOLOGY
- Galectin-1 inhibits the viability, proliferation, and Th1 cytokine production of nonmalignant T cells in patients with leukemic cutaneous T-cell lymphoma
- (2012) F. Cedeno-Laurent et al. BLOOD
- Galectin-3 binds to CD45 on diffuse large B-cell lymphoma cells to regulate susceptibility to cell death
- (2012) M. C. Clark et al. BLOOD
- Incidence, risk factors and outcome of histological transformation in follicular lymphoma
- (2012) Annarita Conconi et al. BRITISH JOURNAL OF HAEMATOLOGY
- Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment
- (2012) Koichi Ito et al. CANCER AND METASTASIS REVIEWS
- Targeting Galectin-1 Overcomes Breast Cancer-Associated Immunosuppression and Prevents Metastatic Disease
- (2012) T. Dalotto-Moreno et al. CANCER RESEARCH
- A Unique Galectin Signature in Human Prostate Cancer Progression Suggests Galectin-1 as a Key Target for Treatment of Advanced Disease
- (2012) D. J. Laderach et al. CANCER RESEARCH
- Regulatory Circuits Mediated by Lectin-Glycan Interactions in Autoimmunity and Cancer
- (2012) Gabriel A. Rabinovich et al. IMMUNITY
- Galectin-1 Deactivates Classically Activated Microglia and Protects from Inflammation-Induced Neurodegeneration
- (2012) Sarah C. Starossom et al. IMMUNITY
- Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi’s sarcoma
- (2012) Diego O. Croci et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Galectin-1 in Melanoma Biology and Related Neo-Angiogenesis Processes
- (2012) Véronique Mathieu et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The microenvironment in follicular lymphoma
- (2011) Daphne de Jong et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Viral induction and targeted inhibition of galectin-1 in EBV+ posttransplant lymphoproliferative disorders
- (2011) J. Ouyang et al. BLOOD
- Proteomic analysis identifies galectin-1 as a predictive biomarker for relapsed/refractory disease in classical Hodgkin lymphoma
- (2011) P. Kamper et al. BLOOD
- Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia
- (2011) Q. Zhou et al. BLOOD
- The aggressiveness of murine lymphomas selected in vivo by growth rate correlates with galectin-1 expression and response to cyclophosphamide
- (2011) Mariano F. Zacarías Fluck et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor Galectin-1 Mediates Tumor Growth and Metastasis through Regulation of T-Cell Apoptosis
- (2011) A. Banh et al. CANCER RESEARCH
- Galectins and microenvironmental niches during hematopoiesis
- (2011) Gabriel A. Rabinovich et al. CURRENT OPINION IN HEMATOLOGY
- A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans
- (2011) Shigeru Tsuboi et al. EMBO JOURNAL
- Galectin-3 Protein Modulates Cell Surface Expression and Activation of Vascular Endothelial Growth Factor Receptor 2 in Human Endothelial Cells
- (2011) Anna I. Markowska et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Galectin-1-mediated cell death is increased by CD30-induced signaling in anaplastic large cell lymphoma cells but not in Hodgkin lymphoma cells
- (2011) Osamu Suzuki et al. LABORATORY INVESTIGATION
- The bone marrow stroma in hematological neoplasms—a guilty bystander
- (2011) Claudio Tripodo et al. Nature Reviews Clinical Oncology
- Multiple Myeloma
- (2011) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Galectin-3C Inhibits Tumor Growth and Increases the Anticancer Activity of Bortezomib in a Murine Model of Human Multiple Myeloma
- (2011) Leonardo Mirandola et al. PLoS One
- Galectin-3 (Gal-3) induced by leukemia microenvironment promotes drug resistance and bone marrow lodgment in chronic myelogenous leukemia
- (2011) M. Yamamoto-Sugitani et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Galectins: regulators of acute and chronic inflammation
- (2010) Fu-Tong Liu et al. Annals of the New York Academy of Sciences
- GCS-100, a novel galectin-3 antagonist, modulates MCL-1, NOXA, and cell cycle to induce myeloma cell death
- (2010) M. J. Streetly et al. BLOOD
- Tumor Cells Secrete Galectin-1 to Enhance Endothelial Cell Activity
- (2010) V. L. Thijssen et al. CANCER RESEARCH
- Modulation of endothelial cell migration and angiogenesis: a novel function for the “tandem-repeat” lectin galectin-8
- (2010) Víctor M. Cárdenas Delgado et al. FASEB JOURNAL
- Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways
- (2010) T Kobayashi et al. LEUKEMIA
- How I treat EBV lymphoproliferation
- (2009) H. E. Heslop BLOOD
- Update on treatment of cutaneous T-cell lymphoma
- (2009) Jennifer M Gardner et al. CURRENT OPINION IN ONCOLOGY
- Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10
- (2009) Juan M Ilarregui et al. NATURE IMMUNOLOGY
- Galectin-1 supports the survival of CD45RA(−) primary myeloma cellsin vitro
- (2008) Saeid Abroun et al. BRITISH JOURNAL OF HAEMATOLOGY
- AP1-Dependent Galectin-1 Expression Delineates Classical Hodgkin and Anaplastic Large Cell Lymphomas from Other Lymphoid Malignancies with Shared Molecular Features
- (2008) S. J. Rodig et al. CLINICAL CANCER RESEARCH
- Restoring the Association of the T Cell Receptor with CD8 Reverses Anergy in Human Tumor-Infiltrating Lymphocytes
- (2008) Nathalie Demotte et al. IMMUNITY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More